Skip to content

CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved.

ASX 200: CSL 1H 2023 earnings preview

Australia's third largest ASX 200 company, CSL, is scheduled to report its 1H2023 earnings on Tuesday, February 14th, 2023 AEDT.

Source: Bloomberg

When will CSL report its latest earnings?

CSL is scheduled to report its 1H2023 earnings on Tuesday, February 14th, 2023 AEDT.

What should traders look out for?

CSL Limited (CSL) is Australia's largest drugmaker, one of the world's largest biotech companies, a leader in flu treatments and plasma protein therapies, and a leading provider of in-licensed vaccines.

CSL is the third largest company in the ASX 200, only behind BHP and CBA. It has an index weighting of ~6.8% and sits under the ASX Heath Care Sector.

Following the acquisition of Vifor Pharma (a Swiss biotech specialising in renal disease and iron deficiency), CSL has a bigger footprint within the industry and a more diversified earnings stream than ever before.

Covid-19 provided a headwind for CSL's supply chains and the collection of plasma, an essential raw material used to produce many of CSL's therapies, which accounts for almost half of CSL's sales.

However, with Covid-19 now mainly in the rear vision mirror, plasma donations in the US are rising, supported by an increase in plasma collection centres and as donors use payments to offset rising living costs. The increase in collections has come despite labour shortages.

Increased collection volumes will help accelerate CSL’s Behring business which develops and manufactures treatments for bleeding disorders, immune deficiencies, and other rare diseases.

CSL earnings – what to expect

CSL’s earnings are heavily screwed to the first half of the year and will be boosted by the Vifor acquisition. There is also the possibility of a $ 200m gain due to movements in the currency.

Full Year NPAT is expected to be in the range of US$2700-$2800m, with approximately US$1650m coming in the first half. The company is expected to pay an interim dividend of US$1.08 per share.

CSL revenues

Source: Trading Economics

CSL shares technical analysis

After breaking out of a long-term trend channel in early February, CSL failed to extend the move above the strong layer of resistance at $320, coming from November 2021 and November 2020 highs.

Since then, the share price of CSL has fallen back into the safety of its long-standing trend channel, postponing, for now, a test of the all-time $342.75 high.

This leaves the share price of CSL delicately perched above a layer of horizontal support at $305/300, and if it falls below there, it would warn that the break higher has failed and of another round of sideways price action within the trend channel.

CSL daily chart

Source Tradingview. The figures stated are as of February 10th, 2023. Past performance is not a reliable indicator of future performance. This report does not contain and is not to be taken as containing any financial product advice or financial product recommendation.

Summary

CSL is scheduled to report its 1H2023 earnings on Tuesday, February 14th, 2023. The market will look for revenue and margin growth as volumes return to and exceed pre-pandemic levels, aided by the acquisition of Vifor.

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. Please see important Research Disclaimer.

Please also note that the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

Start trading forex today

Trade the largest and most volatile financial market in the world.

  • Spreads start at just 0.6 points on EUR/USD
  • Analyse market movements with our essential selection of charts
  • Speculate from a range of platforms, including on mobile

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Monday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.